MX2020002894A - Formulaciones transdermicas. - Google Patents

Formulaciones transdermicas.

Info

Publication number
MX2020002894A
MX2020002894A MX2020002894A MX2020002894A MX2020002894A MX 2020002894 A MX2020002894 A MX 2020002894A MX 2020002894 A MX2020002894 A MX 2020002894A MX 2020002894 A MX2020002894 A MX 2020002894A MX 2020002894 A MX2020002894 A MX 2020002894A
Authority
MX
Mexico
Prior art keywords
transdermal formulations
transdermal
formulations
isothiocyanates
isocyanates
Prior art date
Application number
MX2020002894A
Other languages
English (en)
Inventor
Steven Hoffman
Original Assignee
Tyme Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tyme Inc filed Critical Tyme Inc
Publication of MX2020002894A publication Critical patent/MX2020002894A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/26—Cyanate or isocyanate esters; Thiocyanate or isothiocyanate esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente descripción está dirigida a composiciones transdérmicas que comprenden isotiocianatos o isocianatos.
MX2020002894A 2017-09-15 2018-09-14 Formulaciones transdermicas. MX2020002894A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762559156P 2017-09-15 2017-09-15
PCT/US2018/051010 WO2019055747A1 (en) 2017-09-15 2018-09-14 TRANSDERMAL PREPARATIONS

Publications (1)

Publication Number Publication Date
MX2020002894A true MX2020002894A (es) 2020-10-07

Family

ID=64267888

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020002894A MX2020002894A (es) 2017-09-15 2018-09-14 Formulaciones transdermicas.

Country Status (13)

Country Link
US (1) US20200405680A1 (es)
EP (1) EP3681476B1 (es)
JP (1) JP2020534272A (es)
KR (1) KR20200052934A (es)
CN (1) CN111328278A (es)
AU (1) AU2018331453A1 (es)
BR (1) BR112020005006A2 (es)
CA (1) CA3075091A1 (es)
EA (1) EA202090732A1 (es)
IL (1) IL273087A (es)
MX (1) MX2020002894A (es)
PH (1) PH12020550081A1 (es)
WO (1) WO2019055747A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200282014A1 (en) * 2019-03-05 2020-09-10 Hoffman Technologies Llc Percutaneous anti-microbiota formulations
WO2020232227A1 (en) 2019-05-14 2020-11-19 Tyme, Inc. Compositions and methods for treating cancer
US20230165940A1 (en) * 2020-04-08 2023-06-01 Hoffman Technologies Llc Methods of treating conditions characterized by insulin deficiency in animals
CN115968261A (zh) * 2020-04-23 2023-04-14 Vio化学公司 用于稳定异硫氰酸酯的组合物
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4091557B2 (ja) * 2003-03-18 2008-05-28 株式会社マンダム 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品
ATE552000T1 (de) * 2005-11-15 2012-04-15 Cheng Jingcai Verwendung von isothiocyanat-verbindungen zur behandlung von prostata-erkrankungen und hautkrebs
BE1019434A3 (fr) * 2010-07-23 2012-07-03 Auriga Internat Stabilisation du sulforaphane.
JP2014210725A (ja) * 2013-04-18 2014-11-13 小川香料株式会社 Ｔｒｐ活性化組成物
EP3034076B1 (en) * 2013-08-13 2020-09-30 JC (Wuxi) COMPANY, Inc. Combined application of isothiocyanate compound and anti-cancer medicine
AU2015371253B2 (en) * 2014-12-23 2020-07-23 Steven Hoffman Transdermal formulations
US9687528B2 (en) * 2014-12-23 2017-06-27 Steven Hoffman Transdermal formulations
CN104559760A (zh) * 2014-12-30 2015-04-29 青岛佳尚创意文化有限公司 一种防腐油漆配方

Also Published As

Publication number Publication date
CN111328278A (zh) 2020-06-23
CA3075091A1 (en) 2019-03-21
BR112020005006A2 (pt) 2020-09-15
PH12020550081A1 (en) 2020-10-05
EA202090732A1 (ru) 2020-07-29
US20200405680A1 (en) 2020-12-31
JP2020534272A (ja) 2020-11-26
EP3681476A1 (en) 2020-07-22
IL273087A (en) 2020-04-30
KR20200052934A (ko) 2020-05-15
WO2019055747A1 (en) 2019-03-21
EP3681476B1 (en) 2022-09-14
AU2018331453A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
PH12020550081A1 (en) Transdermal formulations
MX2020009347A (es) Picolinamidas como fungicidas.
PH12019502279A1 (en) Cleaning compositions and uses thereof
PL3668937T3 (pl) Kompozycje i zastosowania Z-1-chloro-2,3,3,3-tetrafluoroprop-1-enu
PH12019500494A1 (en) Formulations of (r)-2-amino-3-phenylpropyl carbamate
MX2018008553A (es) Composiciones que contienen alquil poliurea hidroxilo funcional.
PH12019550235A1 (en) Kinase inhibitors and uses thereof
MX375352B (es) Reguladores de nrf2.
NZ732799A (en) Picolinamides with fungicidal activity
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
MX2020001793A (es) Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos.
TW201614041A (en) Compositions for electronic devices
PH12017500836A1 (en) Transdermal formulations
MX2016011897A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
AU2015317715A8 (en) Compositions comprising recombinant Bacillus cells and a fungicide
MX2017008444A (es) Picolinamidas como fungicidas.
MX2017014459A (es) Compuestos de tioeter como inhibidores de la nitrificacion.
MX2020006596A (es) Hidroxiisoxazolinas y derivados de estos.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2020010657A (es) Derivados de oxadiazolina.
MX391533B (es) Composiciones de saponinas y extractos vegetales.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MY188420A (en) Crystalline forms of (s)-afoxolaner
WO2016020210A8 (en) Factor viii formulation
MX2019010913A (es) Analogos de deutetrabenazina, su preparacion y uso.